Jupiter Neurosciences (JUNS) vs 60 Degrees Pharmaceuticals (SXTP)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Jupiter Neurosciences is the larger company by market cap ($3.6 million vs $3.5 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | JUNS | SXTP |
|---|---|---|
| Share price | $2.73 | $0.9851 |
| Market cap | $3.60M | $3.46M |
| 1-day change | -3.91% | -10.31% |
| Forward P/E | 45.50 | — |
| EPS (TTM) | $-18.94 | $-5.34 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $135.75 | $8.62 |
| 52-week low | $2.25 | $0.84 |
| Distance from 52-week high | -97.99% | -88.57% |
| Average volume | 982.67K | 129.77K |
| Shares outstanding | 1.32M | 3.52M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
JUNS vs SXTP FAQ
Which is bigger, Jupiter Neurosciences or 60 Degrees Pharmaceuticals?
Jupiter Neurosciences (JUNS) is larger, with a market capitalization of $3.60M compared with $3.46M for 60 Degrees Pharmaceuticals (SXTP).
Are Jupiter Neurosciences and 60 Degrees Pharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.